Filter
846
Text search:
assays
Featured
Recommendations
124
New Publications
204
Language
Document type
No document type
448
Guidelines
208
Studies & Reports
92
Manuals
38
Fact sheets
28
Strategic & Response Plan
21
Training Material
5
Situation Updates
3
Resource Platforms
2
Online Courses
1
Countries / Regions
India
47
Western and Central Europe
29
Global
28
Germany
17
Eastern Europe
16
Latin America and the Carribbean
15
Africa
15
South Africa
14
Kenya
13
Russia
12
Uganda
11
Tanzania
11
Sierra Leone
10
Nigeria
10
Brazil
10
East and Southern Africa
10
West and Central Africa
10
Liberia
9
Ukraine
9
Ethiopia
8
Malawi
8
Mozambique
8
Middle East and North Africa
8
Bangladesh
7
Namibia
6
Colombia
6
Nepal
5
Zambia
5
Cambodia
5
Angola
5
USA
4
Syria
4
Argentina
4
Peru
4
South–East Asia Region
4
Venezuela
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
Cameroon
3
Philippines
3
Rwanda
3
Sudan
3
Lesotho
3
Myanmar / Burma
3
Chile
3
Yemen
3
Asia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Ghana
2
Niger
2
Zimbabwe
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Egypt
2
Chad
2
Indonesia
2
Ecuador
2
El Salvador
2
Bolivia
2
Libya
2
Madagascar
2
Eastern Europe and Central Asia
2
Qatar
2
Guinea
1
Guinea-Bissau
1
Morocco
1
Haiti
1
Turkey
1
China
1
Mauritania
1
Benin
1
Dominican Republic
1
Eswatini/ Swaziland
1
Switzerland
1
Cuba
1
Honduras
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
234
Clinical Guidelines
150
Pharmacy & Technologies
48
Public Health
37
Women & Child Health
13
Key Resources
13
Capacity Building
2
Toolboxes
TB
169
COVID-19
122
HIV
108
Rapid Response
56
NTDs
49
Ebola
23
Zika
23
AMR
23
Pharmacy
15
Refugee
14
Polio
10
NCDs
10
Planetary Health
9
Conflict
5
Specific Hazards
5
Mental Health
3
Caregiver
3
Natural Hazards
2
Global Health Education
2
Cholera
1
Health Financing Toolbox
1
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new co
...
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of
...
UNAIDS/WHO 2015 | Reference
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
Current Issüs Arising from Tuberculosis Screening with Interferon-Gamma- Release Assays (IGRAs)
Pneumologie 2015; 69: 271–275
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release
...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB,
...
For the molecular diagnosis of Chagas disease by real-time PCR (polymerase chain reaction), optimization of diagnostic accuracy is desirable. The detection limit of real-time PCR assays for the diagnosis of Trypanosoma cruzi in human serum is affect
...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral
...
